首页 >
法规速递
-
Document: Key elements form: Applicant’s proposal for a paediatric-investigation-plan opinion-2025/8/8
2025-08-10查看详情 > -
Page: Emergency Task Force (ETF)-2025/8/7
2025-08-10查看详情 > -
Document: Composition of the Emergency Task Force (ETF) for preparedness-2025/8/7
2025-08-10查看详情 > -
Document: Superseded - Composition of the Emergency Task Force (ETF) for preparedness-2025/8/7
2025-08-10查看详情 > -
Document: Applications for new human medicines under evaluation: August 2025-2025/8/7
2025-08-10查看详情 > -
Page: Vaccine Monitoring Platform-2025/8/7
2025-08-10查看详情 > -
Document: Vaccine Monitoring Platform: List of EMA-funded studies-2025/8/7
2025-08-10查看详情 > -
Document: Medicine shortage communication (MSC): Zypadhera (olanzapine pamoate monohydrate <210 mg / 300 mg / 405 mg> powder and solvent for prolonged release suspension for injection)-2024/8/7
2025-08-10查看详情 > -
Document: Agenda - Multi-stakeholder workshop on tailored clinical approach for biosimilars-2025/8/7
2025-08-10查看详情 > -
Document: Ketoprofen: European public maximum-residue-limit assessment report (EPMAR) - CVMP-2025/8/6
2025-08-07查看详情 >
